Northwestern Mutual Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$162K Sell
496
-29
-6% -$9.46K ﹤0.01% 1827
2025
Q1
$142K Buy
525
+49
+10% +$13.2K ﹤0.01% 1801
2024
Q4
$112K Sell
476
-47
-9% -$11.1K ﹤0.01% 1881
2024
Q3
$144K Sell
523
-73
-12% -$20.1K ﹤0.01% 1750
2024
Q2
$145K Buy
596
+250
+72% +$60.8K ﹤0.01% 1678
2024
Q1
$51.7K Sell
346
-180
-34% -$26.9K ﹤0.01% 2059
2023
Q4
$101K Buy
526
+46
+10% +$8.81K ﹤0.01% 1781
2023
Q3
$85K Buy
480
+45
+10% +$7.97K ﹤0.01% 1771
2023
Q2
$82.6K Sell
435
-96
-18% -$18.2K ﹤0.01% 1800
2023
Q1
$106K Buy
531
+158
+42% +$31.7K ﹤0.01% 1664
2022
Q4
$88.6K Buy
373
+139
+59% +$33K ﹤0.01% 1706
2022
Q3
$47K Sell
234
-166
-42% -$33.3K ﹤0.01% 1922
2022
Q2
$59K Sell
400
-206
-34% -$30.4K ﹤0.01% 1853
2022
Q1
$98K Buy
606
+5
+0.8% +$809 ﹤0.01% 1712
2021
Q4
$102K Hold
601
﹤0.01% 1700
2021
Q3
$114K Hold
601
﹤0.01% 1569
2021
Q2
$102K Buy
601
+231
+62% +$39.2K ﹤0.01% 1577
2021
Q1
$52K Buy
370
+41
+12% +$5.76K ﹤0.01% 1725
2020
Q4
$43K Buy
329
+21
+7% +$2.75K ﹤0.01% 1694
2020
Q3
$45K Buy
308
+33
+12% +$4.82K ﹤0.01% 1541
2020
Q2
$41K Hold
275
﹤0.01% 1509
2020
Q1
$30K Sell
275
-151
-35% -$16.5K ﹤0.01% 1566
2019
Q4
$49K Sell
426
-514
-55% -$59.1K ﹤0.01% 1468
2019
Q3
$76K Buy
940
+158
+20% +$12.8K ﹤0.01% 1255
2019
Q2
$57K Buy
782
+81
+12% +$5.9K ﹤0.01% 1332
2019
Q1
$66K Buy
701
+511
+269% +$48.1K ﹤0.01% 1235
2018
Q4
$14K Buy
190
+100
+111% +$7.37K ﹤0.01% 1717
2018
Q3
$8K Buy
+90
New +$8K ﹤0.01% 1971
2016
Q3
Sell
-7
Closed 232
2016
Q2
$0 Buy
+7
New ﹤0.01% 2046